The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2022 | The importance of imaging for patients with high-risk disease
Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, discusses the use of imaging techniques for patients with high-risk multiple myeloma, emphasizing the importance of using functional imaging in cases of relapsed disease. Dr Zamagni also explains the need to evaluate alternative treatment options for high-risk patients and the role of imaging in this process. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
Disclosures
Honoraria and advisory board member for Janssen, Sanofi, BMS, Roche, Amgen, GSK, Pfizer
